JERZY SZABLOWSKI, PhD, (Website: szablowskilab.org, Twitter: @jerzyszablowski) is an assistant professor of bioengineering and a core member of the Neuroengineering Initiative at Rice Univ., where he leads the Laboratory for Noninvasive Neuroengineering. He received his BS in biological engineering from the Massachusetts Institute of Technology (MIT) in 2009. Throughout his studies, he worked on engineering protein contrast agents for magnetic resonance imaging (MRI) in collaboration with Alan Jasanoff’s, Robert Langer’s, and Frances Arnold’s research groups and on developing light-activated receptors in Ed Boyden’s synthetic neurobiology group. He received his PhD in bioengineering at the California Institute of Technology (Caltech) while working with Peter Dervan in 2015 on programmable therapeutics for modulating gene expression in animal models of cancer. During his postdoctoral fellowship in Shapiro Laboratory at Caltech, he developed Acoustically Targeted Chemogenetics (ATAC), the first method enabling noninvasive neuromodulation with simultaneous spatial, cell-type, molecular, and temporal precision. In his laboratory, he engineers tools to accelerate the development of treatments for brain disorders using molecular technologies for noninvasive control and monitoring of the brain. He is a recipient of a number of awards, including the Packard Fellowship for Science and Engineering, DARPA Young Faculty Award (YFA), NIH NIBIB Trailblazer, NARSAD Young Investigator, NIH Director’s New Innovator Award (DP2), and others.